KAMU Health Ltd develops and markets digital therapeutics for respiratory-illness care. Through technology, KAMU provides users and their healthcare providers with better data to support treatment while empowering users to take a proactive role in managing their conditions. All KAMU’s services are founded on the latest evidence-based medicine and comply with local medical regulations in the US and Europe. KAMU Health Ltd is headquartered in Helsinki, Finland.